Your session is about to expire
← Back to Search
This trial is testing whether leucine will help increase muscle mass in people with cirrhosis, by looking at the response to leucine in cirrhotic patients compared to a control group. They will measure this by looking at the rate of protein synthesis in muscle, and how this changes in response to leucine.
- Liver Cirrhosis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- The child has a score higher than 9 on a specific evaluation.You have swelling in your feet that goes above your ankles.You have other health conditions or take certain medications that can affect your muscle mass.You have a severe infection called sepsis or a condition affecting your brain called encephalopathy.Your liver cancer is beyond a certain stage that is considered operable.You haven't used alcohol or recreational drugs for at least 6 months.
- Group 1: Leucine enriched essential amino acid
- Group 2: Balanced amino acid supplement
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I potentially be included in this clinical examination?
"This clinical study is accepting up to 32 people with fibrosis who are between 18 and 70 years old."
What is the sample population of this research endeavor?
"Indeed, clinicaltrials.gov points to this trial as actively searching for participants who can be found at 1 medical centre. The study was first posted on August 5th 2013 and recently updated on March 7th 2022 with the aim of recruiting 32 patients in total."
Is geriatric age eligibility taken into account for this research?
"The age range for this trial is limited to 18-70. There are 76 clinical studies conducted on people younger than 18 and 429 trials which focus on elderly individuals greater than 65 years of age."
Are there any vacancies available for prospective participants in this experiment?
"Correct. Per the clinicaltrials.gov website, this medical investigation is in progress and accepting participants; it was launched on August 5th 2013, with updates occurring most recently on March 7th 2022. 32 patients must be recruited from a single site for proper completion of the study's protocol."
Share this study with friends